Royal London Asset Management LTD Eli Lilly & CO Transaction History

Royal London Asset Management LTD

$39.3 Billion
Q1 2024

A detailed history of Royal London Asset Management LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Royal London Asset Management LTD holds 849,646 shares of LLY stock, worth $770 Million. This represents 1.68% of its overall portfolio holdings.

Number of Shares

849,646

Previous 890,201 4.56%

Holding current value

$770 Million

Previous $519 Million 27.38%

% of portfolio

1.68%

Previous 1.51%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $24 Million - $32.1 Million	-40,555 Reduced 4.56%	849,646 $661 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $8 Million - $9.43 Million	-15,231 Reduced 1.68%	890,201 $519 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $157 Million - $216 Million	-361,200 Reduced 28.52%	905,432 $486 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $38.9 Million - $52.1 Million	111,000 Added 9.61%	1,266,632 $594 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $21.3 Million - $25 Million	68,611 Added 6.31%	1,155,632 $397 Million

Q4 2022 Feb 09, 2023	BUY	$321.55 - $374.67 $54.4 Million - $63.3 Million	169,047 Added 18.42%	1,087,021 $398 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $6.2 Million - $7.07 Million	-20,915 Reduced 2.23%	917,974 $297 Million
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $28.6 Million - $33.5 Million	102,433 Added 12.25%	938,889 $305 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $4.35 Million - $5.4 Million	18,522 Added 2.26%	836,456 $240 Million
Q4 2021 Oct 18, 2022	BUY	$224.85 - $279.04 $2.2 Million - $2.72 Million	9,765 Added 1.21%	817,934 $226 Million
Q4 2021 Jan 18, 2022	BUY	$224.85 - $279.04 $2.2 Million - $2.72 Million	9,765 Added 1.21%	817,934 $226 Million
Q3 2021 Oct 18, 2022	SELL	$221.6 - $272.71 $21.4 Million - $26.3 Million	-96,492 Reduced 10.67%	808,169 $187 Million
Q3 2021 Nov 02, 2021	SELL	$221.6 - $272.71 $21.4 Million - $26.3 Million	-96,492 Reduced 10.67%	808,169 $187 Million
Q2 2021 Oct 18, 2022	SELL	$180.55 - $233.54 $6.18 Million - $7.99 Million	-34,228 Reduced 3.65%	904,661 $208 Million
Q2 2021 Jul 14, 2021	BUY	$180.55 - $233.54 $5.01 Million - $6.48 Million	27,756 Added 3.17%	904,661 $209 Million
Q1 2021 Oct 17, 2022	SELL	$164.32 - $212.72 $10.2 Million - $13.2 Million	-61,984 Reduced 6.6%	876,905 $164 Million
Q1 2021 Apr 13, 2021	BUY	$164.32 - $212.72 $4.52 Million - $5.85 Million	27,483 Added 3.24%	876,905 $164 Million
Q4 2020 Jan 29, 2021	BUY	$130.46 - $172.63 $2.91 Million - $3.85 Million	22,280 Added 2.69%	849,422 $143 Million
Q3 2020 Nov 04, 2020	BUY	$146.22 - $169.13 $21.1 Million - $24.4 Million	144,349 Added 21.14%	827,142 $121 Million
Q2 2020 Jul 31, 2020	SELL	$136.42 - $164.18 $1.99 Million - $2.39 Million	-14,564 Reduced 2.09%	682,793 $111 Million
Q1 2020 May 01, 2020	BUY	$119.05 - $147.35 $90,835 - $112,428	763 Added 0.11%	697,357 $96.5 Million
Q4 2019 Feb 05, 2020	BUY	$106.92 - $132.43 $1.57 Million - $1.95 Million	14,720 Added 2.16%	696,594 $91.5 Million
Q3 2019 Nov 12, 2019	BUY	$106.79 - $116.16 $300,720 - $327,106	2,816 Added 0.41%	681,874 $76.2 Million
Q2 2019 Jul 31, 2019	BUY	$110.79 - $129.32 $3.53 Million - $4.12 Million	31,832 Added 4.92%	679,058 $75.2 Million
Q1 2019 Apr 30, 2019	SELL	$111.31 - $131.02 $2.78 Million - $3.27 Million	-24,934 Reduced 3.71%	647,226 $0
Q4 2018 Jan 29, 2019	BUY	$105.9 - $118.64 $16.3 Million - $18.3 Million	154,323 Added 29.8%	672,160 $76.8 Million
Q3 2018 Nov 08, 2018	SELL	$85.86 - $107.31 $619,737 - $774,563	-7,218 Reduced 1.37%	517,837 $0
Q2 2018 Sep 19, 2018	BUY	$75.7 - $86.88 $39.7 Million - $45.6 Million	525,055 New	525,055 $44.8 Million

Others Institutions Holding LLY

# of Institutions

3,721

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $862B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal London Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Royal London Asset Management LTD with notifications on news.

Account

Royal London Asset Management LTD Eli Lilly & CO Transaction History